Japan, April 17 -- CORSAIR PHARMA INC has got intellectual property rights for 'TREPROSTINIL DERIVATIVES AND COMPOSITIONS AND USES THEREOF.' Other related details are as follows:
Application Number: JP,2021-151659
Category (FI): C07D307/24,C07D309/08,A61K31/341,A61K9/70,401,C07D305/08,A61K31/351,A61K31/337,A61K31/216,A61K31/265,A61K31/215,A61K31/222,A61P25/04,A61P29/02,C07C69/74@Z,C07C69/708@Z,C07C69/67,C07C69/30,A61P35/00,A61P43/00,105,A61P37/04,A61P13/12,A61P17/02,A61P9/10,A61P9/10,101,A61P9/04,A61P11/06,A61P9/12,A61P11/00,C07C69/712@Z,C07C69/96@Z,C07C69/75@Z
Stage: Grant (IP right granted following substantive examination.)
Filing Date: Sept. 17, 2021
Publication Date: Jan. 11, 2022
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.